US EditionStudy: COVID mRNA Vaccines Boost Cancer Survival
A study of over 1,000 patients found COVID-19 mRNA vaccines nearly doubled survival times when combined with immunotherapy for advanced lung and skin cancers.
- On Wednesday, researchers reported in journal Nature that advanced lung and skin cancer patients receiving Pfizer or Moderna shots within 100 days of immune checkpoint inhibitors lived substantially longer.
- The team explains that mRNA vaccines act like an alarm triggering T-cells and lymph nodes to recognize and kill tumour cells, potentially sensitising immune-resistant tumours to checkpoint inhibitors.
- Detailed figures show the analysis used records of nearly 1,000 patients including 884 advanced lung cancer patients, 180 vaccinated lung cancer patients, and 210 metastatic melanoma patients, with survival rising from 26.7 months to up to 40 months.
- Researchers are preparing randomized clinical trials, including a nationwide clinical trial in lung cancer due to start before the end of the year, to test adding mRNA vaccines to standard care for millions of patients.
- Because the analysis was retrospective, the study is not randomized and confounding could explain results; follow-up faces skepticism and funding pressures after Health Secretary Robert F. Kennedy Jr. cut $500 million.
231 Articles
231 Articles
COVID-19 Vaccines May Help Cancer Patients, Researchers Say
Patients with a particular form of lung cancer who received a COVID-19 vaccine lived longer than those who did not, researchers said in a new study. Patients who received a Pfizer-BioNTech or Moderna COVID-19 vaccine within 100 days of starting immunotherapy drugs survived longer on average than patients who did not, researchers with the University of Florida and University of Texas said in the paper, which was published by Nature on Oct. 22. “T…
mRNA vaccine boosted immune response, life expectancy for cancer patients, UF research finds
(Photo courtesy UF Health)University of Florida researchers found that advanced lung and skin cancer patients lived “significantly longer” after receiving the COVID-19 mRNA vaccine. This finding, in conjunction with the University of Texas MD Anderson Cancer Center, comes as the DeSantis administration attempts to ban vaccine mandates, including for public school students. “This is one of the most exciting observations I have seen in my 20-year …
COVID vaccines show an unexpected benefit: helping fight cancer
Personalized vaccines that steer the immune system to fight unique cancer cells show promise, but another powerful way to treat cancer might be hiding in plain sight. People being treated for advanced skin and lung cancer lived longer if they had received a Moderna or Pfizer COVID-19 vaccine, according to new research published in the journal Nature. Both vaccines work using messenger RNA, which prompts cells to make a virus-like protein that tr…
A preliminary study conducted in the United States and published in Nature, which was carried out in animal models and clinical studies, showed that these immunizers, along with immunotherapy, improved immune activation against tumours.
Coverage Details
Bias Distribution
- 53% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
